R56AI140872 (HOTEZ, PETER J)Mar 11, 2020 - Feb 28, 2021 NIH Development of a safe and effective RBD-based vaccine against MERS-CoV Role: Principal Investigator |
|
R21AI144555 (HOTEZ, PETER J)Feb 19, 2019 - Jan 31, 2021 NIH A novel mucosal trichuriasis vaccine for Th2 immune protection. Role: Principal Investigator |
|
R01AI098775 (HOTEZ, PETER J)May 4, 2012 - Jul 31, 2017 NIH RBD recombinant protein-based SARS vaccine for biodefense Role: Principal Investigator |
|
R56AI090577 (HOTEZ, PETER J)Jan 1, 2011 - Sep 30, 2013 NIH PRODUCT DEVELOPMENT OF A MEMBRANE TETRASPANIN VACCINE AGAINST SCHISTOSOMIASIS Role: Principal Investigator |
|
R41AI040447 (HOTEZ, PETER J)Sep 30, 1996 - Sep 29, 1998 NIH RECOMBINANT HOOKWORM (NEMATODE) VACCINE Role: Principal Investigator |
|
R01AI032726 (HOTEZ, PETER J)Dec 1, 1992 - Feb 28, 2004 NIH HOOKWORM LARVAL INFECTIVITY AND DEVELOPMENT Role: Principal Investigator |
|
R29AI032726 (HOTEZ, PETER J)Dec 1, 1992 - Nov 30, 1999 NIH HOOKWORM LARVAL INFECTIVITY AND DEVELOPMENT Role: Principal Investigator |